Nevertheless, the present study revealed that, in addition to activating RSK1 and RSK2, FLT3-ITD is able to increase expression of RSK1, but not RSK2, through mechanisms possibly involving c-Myc, but not PIM, in some AML cells. The gene discussed is FLT3; the disease is acute myeloid leukemia.